Gregory Hapgood

12PUBLICATIONS
85CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAnimal immunologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Sep 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.

Franck Morschhauser, Gilles Salles, Laurie H Sehn

|Feb 13, 2025
An Economic Evaluation of the TROG 99.03 Trial: Systemic Therapy After Radiotherapy in Early-Stage Follicular Lymphoma.

Daniel Erku, Joshua W D Tobin, John F Seymour

|Jan 18, 2025
Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature review.

Luke Wang, Eliza Chung, Cameron Wellard

|Oct 13, 2024
The value of semiquantitative PET features and end-of-therapy PET in grade 3B follicular lymphoma.

Allison Barraclough, Sze Ting Lee, Diego Villa

|Aug 05, 2024
Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.

Joshua W D Tobin, Greg Hapgood, Anna Johnston

Pageof 2

Frequent Collaborators

5 joint publications

Eliza Hawkes

4 joint publications

Judith Trotman

4 joint publications

Matthew Ku

4 joint publications

Michael Dickinson